The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?

Por Millan, Mark J.
Publicado em 2014

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

Por Millan, Mark J.
Publicado no Neurotherapeutics (2009)

Differential modulation by GTPγS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [(3)H]-WAY100,635

Por Newman-Tancredi, Adrian, Verrièle, Laurence, Millan, Mark J
Publicado em 2001

S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT(1A) receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal...

Por Carli, Mirjana, Balducci, Claudia, Millan, Mark J, Bonalumi, Pierenrico, Samanin, Rosario
Publicado em 1999

Inhibition of the constitutive activity of human 5-HT(1A) receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635

Por Newman-Tancredi, Adrian, Conte, Caroline, Chaput, Christine, Spedding, Michael, Millan, Mark J
Publicado em 1997

h5-HT(1B) receptor-mediated constitutive Gα(i3)-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT

Por Newman-Tancredi, Adrian, Cussac, Didier, Marini, Laetitia, Touzard, Manuelle, Millan, Mark J
Publicado em 2003

Evidence for functional trace amine associated receptor-1 in normal and malignant B cells

Por Wasik, Agata M., Millan, Mark J., Scanlan, Thomas, Barnes, Nicholas M., Gordon, John
Publicado no Leuk Res (2011)

Association of Changes in Norepinephrine and Serotonin Transporter Expression with the Long-Term Behavioral Effects of Antidepressant Drugs

Por Zhao, Zaorui, Zhang, Han-Ting, Bootzin, Elianna, Millan, Mark J, O’Donnell, James M
Publicado em 2008

Functional Homomers and Heteromers of Dopamine D(2L) and D(3) Receptors Co-exist at the Cell Surface

Por Pou, Chantevy, Mannoury la Cour, Clotilde, Stoddart, Leigh A., Millan, Mark J., Milligan, Graeme
Publicado em 2012

The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats

Por Weber, Martin, Chang, Wei-Li, Breier, Michelle R., Yang, Alex, Millan, Mark J., Swerdlow, Neal R.
Publicado em 2010

Selective Blockade of Dopamine D(3) Receptors Enhances while D(2) Receptor Antagonism Impairs Social Novelty Discrimination and Novel Ob...

Por Watson, David JG, Loiseau, Florence, Ingallinesi, Manuela, Millan, Mark J, Marsden, Charles A, Fone, Kevin CF
Publicado em 2012

Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells

Por Ledonne, Ada, Federici, Mauro, Giustizieri, Michela, Pessia, Mauro, Imbrici, Paola, Millan, Mark J, Bernardi, Giorgio, Mercuri, Nicola B
Publicado em 2010

Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank

Por Scarr, Elizabeth, Millan, Mark J., Bahn, Sabine, Bertolino, Alessandro, Turck, Christoph W., Kapur, Shitij, Möller, Hans-Jürgen, Dean, Brian
Publicado no Int J Neuropsychopharmacol (2015)

Design, Synthesis, and Optimization of Balanced Dual NK(1)/NK(3) Receptor Antagonists

Por Hanessian, Stephen, Jennequin, Thomas, Boyer, Nicolas, Babonneau, Vincent, Soma, Udaykumar, Mannoury la Cour, Clotilde, Millan, Mark J., De Nanteuil, Guillaume
Publicado em 2014

Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser(280) by Hallucinogenic versus Nonhallucinogenic Agonists

Por Karaki, Samah, Becamel, Carine, Murat, Samy, Mannoury la Cour, Clotilde, Millan, Mark J., Prézeau, Laurent, Bockaert, Joël, Marin, Philippe, Vandermoere, Franck
Publicado em 2014

Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes

Por Vinkers, Christiaan H., Hendriksen, Hendrikus, van Oorschot, Ruud, Cook, James M., Rallipalli, Sundari, Huang, Shengming, Millan, Mark J., Olivier, Berend, Groenink, Lucianne
Publicado em 2011

The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats

Por Peng, Xiao-Qing, Ashby, Charles R., Spiller, Krista, Li, Xia, Li, Jie, Thomasson, Nitza, Millan, Mark J., Mocaër, Elisabeth, Muńoz, Carmen, Gardner, Eliot L., Xi, Zheng-Xiong
Publicado em 2009

The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D(3) and D(2) Receptors

Por Silvano, Elena, Millan, Mark J., la Cour, Clotilde Mannoury, Han, Yang, Duan, Lihua, Griffin, Suzy A., Luedtke, Robert R., Aloisi, Gabriella, Rossi, Mario, Zazzeroni, Francesca, Javitch, Jonathan A., Maggio, Roberto
Publicado em 2010

Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome

Por Darville, Hélène, Poulet, Aurélie, Rodet-Amsellem, Frédérique, Chatrousse, Laure, Pernelle, Julie, Boissart, Claire, Héron, Delphine, Nava, Caroline, Perrier, Anselme, Jarrige, Margot, Cogé, Francis, Millan, Mark J., Bourgeron, Thomas, Peschanski, Marc, Delorme, Richard, Benchoua, Alexandra
Publicado no EBioMedicine (2016)

Convergence of Melatonin and Serotonin (5-HT) Signaling at MT(2)/5-HT(2C) Receptor Heteromers

Por Kamal, Maud, Gbahou, Florence, Guillaume, Jean-Luc, Daulat, Avais M., Benleulmi-Chaachoua, Abla, Luka, Marine, Chen, Patty, Kalbasi Anaraki, Dina, Baroncini, Marc, Mannoury la Cour, Clotilde, Millan, Mark J., Prevot, Vincent, Delagrange, Philippe, Jockers, Ralf
Publicado no J Biol Chem (2015)